cephalosporin c has been researched along with Bacterial Infections, Gram-Positive in 181 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.55) | 18.7374 |
| 1990's | 59 (32.60) | 18.2507 |
| 2000's | 59 (32.60) | 29.6817 |
| 2010's | 56 (30.94) | 24.3611 |
| 2020's | 6 (3.31) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SC; Chen, PY; Chen, YC; Chuang, YC; Sheng, WH; Wang, JT | 1 |
| Hartung, A; Makarewicz, O; Pletz, MW; Thieme, L | 1 |
| Hsueh, PR; Jean, SS; Ko, WC; Lee, WS | 1 |
| Cantón, R; Gomes, R; Martins-Oliveira, I; Pérez-Viso, B; Pina-Vaz, C; Quintas, S; Rodrigues, AG; Silva-Dias, A | 1 |
| Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT | 1 |
| Heisel, RW; Lim, SH; Mascara, GP; Oleksiuk, LM; Sutton, RR; Weber, DR; Winger, DG | 1 |
| Morisawa, Y; Sasahara, T; Suzuki, J; Toshima, M | 1 |
| Arias, CA; Beganovic, M; LaPlante, KL; Luther, MK; Rice, LB; Rybak, MJ | 1 |
| Hartung, A; Klinger-Strobel, M; Makarewicz, O; Pletz, MW; Stein, C; Thieme, L | 1 |
| Shantier, SW | 1 |
| Hwang, H; Kim, B | 1 |
| Destache, CJ; Guervil, DJ; Kaye, KS | 1 |
| Duncan, LR; Flamm, RK; Hamed, KA; Mendes, RE; Pfaller, MA; Sader, HS; Shortridge, D; Smart, JI | 1 |
| Kamath, PS; Lennon, RJ; Shah, VH; Simonetto, DA; Sunjaya, DB | 1 |
| Attanasio, V; Bernardo, M; Carozza, A; Francisci, D; Oltolini, C; Pallotto, C; Palmiero, G; Ripa, M; Scarpellini, P; Tascini, C | 1 |
| Rahiman, S; Tantry, BA | 1 |
| Adam, HJ; Baxter, MR; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Walkty, AJ; Zhanel, GG | 1 |
| Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Flamm, RK; Jones, RN; Sader, HS; Stilwell, MG | 1 |
| Cattoir, V; Giard, JC | 1 |
| Correa Signoretti, FG; Gomes, BP; Grecca, FS; Jacinto, RC; Montagner, F; Scheffer de Mattos, V | 1 |
| Arias, CA; Carvajal, LP; Díaz, L; Munita, JM; Panesso, D; Reyes, J; Rincón, S | 1 |
| Seifert, H | 1 |
| Azzalis, LA; Bacci, MR; Bruniera, FR; Campos Junqueira, VB; da Luz Gonçalves Pedreira, M; Feder, D; Ferreira, FM; Fonseca, FL; Saviolli, LR; Sorgini Peterlini, MA | 1 |
| Bill, C; Havlichek, D; Scharmen, A; Smith, C; Stein, GE; Yasin, F | 1 |
| Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G | 1 |
| Chan, JF; Yuen, KY | 1 |
| Abbott, AN; Werth, BJ | 1 |
| Edwards, JK | 1 |
| Mensa, J; Morata, L; Soriano, A | 1 |
| Berghofen, A; Krämer, BK; Krüger, B; Mircheva, M; Popa, C | 1 |
| Boyles, T | 1 |
| Kielstein, JT; Schmidt, JJ | 1 |
| Darouiche, RO; Umeh, O; Wagenlehner, FM | 1 |
| Armstrong, ES; Farrell, DJ; Palchak, M; Steenbergen, JN | 1 |
| Albini, TA; Flynn, HW; Kuriyan, AE; Miller, D; Pathengay, A; Relhan, N | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Agga, GE; Arthur, TM; Schmidt, JW | 1 |
| Bordi, E; D'Arezzo, S; De Giuli, C; Di Caro, A; Mazzarelli, A; Nisii, C; Paglia, MG; Petrosillo, N; Taglietti, F; Venditti, C; Vulcano, A | 1 |
| Addison, NO; Awuah-Mensah, G; Labi, AK; Labi, JE; Obeng-Nkrumah, N | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Chung, GE; Kim, BH; Kim, EC; Kim, W; Kim, YJ; Lee, HS; Lee, JH; Myung, SJ; Yoon, JH | 1 |
| Cruz, OL; de Oliveira Penido, N; Inoue, DP; Testa, JR | 1 |
| Echevarria, K; Lewis, JS; Towne, TG | 1 |
| Chiquet, C; Cornut, PL | 1 |
| Corey, GR; Kanafani, ZA | 1 |
| Barbour, A; Derendorf, H; Rand, KH; Schmidt, S | 1 |
| Camarasa, A; Chiner, E; Sancho-Chust, JN | 1 |
| Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F | 1 |
| El Solh, A | 1 |
| Rice, LB | 2 |
| Deresinski, SC; Schirmer, PL | 1 |
| Eliopoulos, GM | 1 |
| Acred, P; Ryan, DM; Sowa, MA; Watts, CM | 1 |
| Eames, T; Grabein, B; Kroth, J; Wollenberg, A | 1 |
| Choe, KW; Jang, HC; Jeon, JH; Kim, EC; Kim, HB; Kim, NJ; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Chang, KC; Lee, CC; Sun, CY; Wu, MS | 1 |
| Alexander, SR; Feneberg, R; Schaefer, F; Sutherland, SM; Warady, BA | 1 |
| Fukumoto, K; Matsui, K; Oishi, T; Taguchi, T; Tsukano, S; Uchiyama, M; Ueno, K | 1 |
| Bacigalupo, A; Boni, L; Cappellano, P; Del Bono, V; Dominietto, A; Gualandi, F; Lamparelli, T; Mikulska, M; Prinapori, R; Raiola, AM; Van Lint, MT; Viscoli, C | 1 |
| Dryden, MS; Flamm, RK; Kozlov, RS; Läuffer, JM; Lee, E; Morrissey, I; Quintana, A; Rossolini, GM | 1 |
| Gupta, S; Muralidharan, S; Srinivasa, H | 1 |
| Adam, HJ; Hoban, DJ; Karlowsky, JA; Laverdière, M; Walkty, A; Zhanel, GG | 1 |
| Mercuri, LG; Psutka, D | 1 |
| Matana Kaštelan, Z; Matana, A; Žagar, D | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| Hall, CL; Hoff, JS; Kristich, CJ; Little, JL | 1 |
| Homann, C; Knudsen, JD; Moser, C; Novovic, S; Olsen, H; Semb, S | 1 |
| Afaneh, CI; Barie, PS; Dakin, GF; Ho, VP; Keel, R; Nicolau, DP; Pomp, A; Rich, BS; Turbendian, H | 1 |
| Baier, M; Bruns, T; Pfister, W; Pletz, MW; Reuken, PA; Stallmach, A | 1 |
| Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
| Suzuki, T | 1 |
| Abbadi, DR; Alshabani, K; Bai, S; Bathina, P; Chidurala, S; Chowdary, D; Das, M; Diviti, S; Doddamani, R; Govindavarjhulla, A; Guddati, H; Guddeti, RR; Gudur, UM; Hayakawa, K; Joseph, M; Kakarlapudi, H; Kannekanti, N; Kaye, KS; Lephart, PR; Lohithaswa, S; Mallad, A; Marchaim, D; Martin, ET; Mundra, VR; Palla, M; Pogue, JM; Policherla, R; Pulluru, H; Rybak, MJ; Shashidharan, SP; Sukayogula, K; Vemuri, P | 1 |
| Bheemreddy, S; Biedron, C; Chalana, IK; Collins, V; Hayakawa, K; Ho, K; Judge, T; Kamatam, S; Kaye, KS; Khammam, V; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Parveen, S; Pogue, JM; Reddy, SM; Rybak, MJ; Tiwari, N; Tumma, RS; Yousuf, A | 1 |
| Boĭko, VV; Ivanova, IuV | 1 |
| Carmeli, Y; Eliopoulos, GM; Samore, MH | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 2 |
| Chen, JY; Chen, YS; Huang, CK; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, HC; Wann, SR; Yen, MY | 1 |
| Ahern, JW; Alston, WK; Hood, V; Possidente, CJ | 1 |
| Aeberhard, P; Billing, A; Böcker, I; Gebhard, B; Ohmann, C; Röhrborn, A; Schäfer, V; Schöffel, U; Wacha, H | 1 |
| Flores, C; Goldani, LZ; Hadlich, E; Maguilnik, I | 1 |
| Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T | 1 |
| Draghi, DC; Jones, ME; Karlowsky, JA; Nathwani, D; Sahm, DF; Thornsberry, C | 1 |
| Perry, CM; Scott, LJ | 1 |
| Chatterjee, A; Moland, ES; Thomson, KS | 1 |
| Dittrich, E; Guttmann, C; Meyer, B; Schmaldienst, S; Thalhammer, F | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Lin, CY; Wang, HH | 1 |
| Green, GR; Nadarajah, K; Naglak, M | 1 |
| Lindeman, CJ; Papp, G; Passmore, CA; Sherington, J; Skogerboe, TL; Stegemann, MR; Weigel, DJ | 1 |
| Fritsche, TR; Jones, RN; Pottumarthy, S; Sader, HS | 1 |
| Alborzi, A; Dehghani, SM; Haghighat, M; Imanieh, MH; Kalani, M; Pourabbas, B | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Anzueto, A; Bishai, WR; Pottumarthy, S | 1 |
| Arias, CA; Murray, BE; Panesso, D; Singh, KV | 2 |
| Fraser, A; Leibovici, L; Paul, M; Sarid, N; Yahav, D | 1 |
| Noel, GJ | 1 |
| Corcoran, E; Dudley, MN; Griffith, DC; Rodriguez, D | 1 |
| Amsler, K; Heep, M; Noel, GJ; Pypstra, R; Solomkin, JS; Strauss, RS | 1 |
| Aron, DC; Bonomo, RA; Capitano, B; Donskey, CJ; Linden, PK; Muto, CA; Ndirangu, M; Paterson, DL; Potoski, BA | 1 |
| Bagchi, P; Bush, K; Ianus, J; Noel, GJ; Strauss, RS | 1 |
| Aksoy, DY; Unal, S | 1 |
| Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE | 1 |
| Deresinski, SC | 1 |
| Jadoul, M; Labriola, L | 1 |
| Anderson, SD; Gums, JG | 1 |
| Choi, EC; Choi, KH; Choi, MJ; Kim, BO; Kim, DJ; Park, NJ; Shim, JS; Yu, YH | 1 |
| Isenberg, HD; Lam, S; Morthland, VH; Pfaller, MA; Singer, C; Tucci, V | 1 |
| Hof, H | 1 |
| King, A; Phillips, I | 1 |
| Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R | 1 |
| Swartz, MN | 1 |
| Clark, CD; Dunagan, WC; Picus, D | 1 |
| Barriere, SL | 1 |
| Ariza, J; Gudiol, F; Martin, R; Pallares, R; Peña, C; Pujol, M | 1 |
| Blanco, JD; Eriksen, N; Graham, JM; Magee, KP; Monga, M; Oshiro, BT | 1 |
| Acar, JF; Goldstein, FW; Gutmann, L; Mainardi, JL | 1 |
| Elliott, JA; Facklam, RR | 1 |
| Dufort, G; Olivé, T; Ortega, JJ; Ventura, C | 1 |
| Lee, CP; Lim, AS; Tan, DT | 1 |
| Kim, IC; Kim, MY; Kim, YZ; Kwak, JH; Oh, JI; Paek, KS | 1 |
| Benko, AS; Cappelletty, DM; Kruse, JA; Rybak, MJ | 1 |
| Chesney, PJ; English, BK | 1 |
| Deshpande, AK; Kaundinya, DV; Shah, SS | 1 |
| Hafner, A; John, J; Riley, LW; Roberts, RB; Tornieporth, NG | 1 |
| Budanov, SV; Khess, R | 1 |
| Shinagawa, N | 1 |
| Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
| Barnett, ED; Klein, JO | 1 |
| Schmid, P; Shpigel, NY | 1 |
| Fraise, AP | 1 |
| Klastersky, J | 1 |
| Wolff, M | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Besnier, JM; Leport, C | 1 |
| Mini, E; Mosconi, G; Periti, P | 1 |
| Budanov, SV | 1 |
| Kallio, MJ; Peltola, H; Unkila-Kallio, L | 1 |
| Munakata, K; Satoh, M; Takeuchi, H; Yoshida, O | 1 |
| Horiba, M; Kumazawa, J; Matsumoto, T; Naide, Y | 1 |
| Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP | 1 |
| Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB | 1 |
| Jones, RN; Marshall, SA; Varnam, DJ | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Beilman, GJ; Dahms, RA; Dunn, DL; Johnson, EM; Lee, JT; Statz, CL | 1 |
| Johnson, MS; Moresco, KP; Namyslowski, J; Patel, NH; Shah, H; Trerotola, SO | 1 |
| Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R | 1 |
| Bartlett, ST; Keay, S; McCarter, RJ; Morris, JG; Oldach, DW; Pfundstein, J; Qaiyumi, SQ; Roghmann, MC; Schwalbe, RS; Schweitzer, E | 1 |
| Björkholm, M; Dornbusch, K; Engervall, P; Kalin, M | 1 |
| Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
| Hatano, S; Kakeya, N; Kasai, M; Kitagawa, M; Nishimura, K; Shirahase, H; Yoshimi, A | 1 |
| Hoogkamp-Korstanje, JA; Schouten, MA; Voss, A | 1 |
| Aswapokee, N; Bowonwatanuwong, C; Chayakul, P; Chetchotisakd, P; Dusitnanond, V; Kulpradist, SA; Leelasupasri, S; Rajanuwong, A; Suttinont, C; Suwangool, P | 1 |
| Clark, CE; Shufflebarger, HL | 1 |
| Agraharkar, M; Galen, M; Klevjer-Anderson, P; Rubinstien, E | 1 |
| Akhmedova, LI; Beloborodov, VB; Bogomolova, NS; Bol'shakov, LV; Dekhnich, AV; Iakovlev, VP; Karabak, VI; Malikov, VE; Pavlova, MV; Polikarpova, SV; Rudnov, VA; Sidorenko, SV; Strachunskiĭ, LS | 1 |
| Beloborodova, NV; Biriukov, AV; Krutskikh, EN; Kurchavov, VA; Rogatina, EL; Vostrikova, TIu | 1 |
| Rybkin, AK; Shliapnikov, SA | 1 |
| Giamarellou, H | 1 |
| Hoang, LM; Stiver, G | 1 |
| Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P | 1 |
| De Soyza, A; Gould, K; Higgins, B | 1 |
| Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW | 1 |
| Berman, S; DePauw, B; Feld, R; Ho, W; Keating, A | 1 |
| Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M | 1 |
| Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA | 1 |
| Cornaglia, G; Fontana, R; Ligozzi, M; Mazzariol, A | 1 |
| Dikov, I; Dimitrov, A; Kostov, I; Nikolov, A; P'nevska, M | 1 |
| Goa, KL; Ormrod, D; Scott, LJ | 1 |
| Bertrand, X; Talon, D; Thouverez, M | 1 |
| Bonner, DP; Chaniewski, S; Clark, J; Drain, R; Ferraro, C; Fung-Tomc, JC; Gradelski, E; Huczko, E; Kolek, B; Minassian, B; Tsai, YH; Yang, H | 1 |
| Carmeli, Y; Cosgrove, S; Harbarth, S | 1 |
| Chambers, ST | 1 |
| Alonso, T; Liñares, J; Pérez, JL | 1 |
| Fujimoto, S; Kobamatsu, Y; Makinoda, S; Okuda, T; Sakuragi, N; Tamaki, J; Tanaka, T; Yamada, T | 1 |
39 review(s) available for cephalosporin c and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Peripherally inserted central catheter-related bloodstream infection due to Tsukamurella pulmonis: a case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Actinobacteria; Administration, Intravenous; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Catheter-Related Infections; Catheterization, Peripheral; Cefozopran; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2017 |
A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin-Resistant Enterococci | 2018 |
Review on the Characteristic, Properties and Analytical Methods of Cefquinomesulphate: ß-lactam Veterinary Drug.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Molecular Structure; Veterinary Drugs | 2020 |
Antibiotic resistance in Enterococcus faecium clinical isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Fluoroquinolones; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Penicillins | 2014 |
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Genes, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Staphylococcal Infections; Tigecycline; Vancomycin | 2014 |
The use of vancomycin with its therapeutic and adverse effects: a review.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neutropenia; Vancomycin | 2015 |
New antibiotics against gram-positives: present and future indications.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Oxazoles | 2015 |
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
Topics: Anti-Bacterial Agents; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Tetracyclines; Vancomycin; Vancomycin Resistance; Visual Acuity | 2016 |
Ceftaroline: a cephalosporin with expanded Gram-positive activity.
Topics: Adult; Animals; Ceftaroline; Cephalosporins; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Mice; Skin Diseases, Bacterial; Treatment Outcome | 2009 |
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Treatment Outcome; United States | 2009 |
Ceftobiprole: a new broad spectrum cephalosporin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Cross Infection; Drug Interactions; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Treatment Outcome | 2009 |
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Skin Diseases, Bacterial; Treatment Outcome | 2009 |
Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Teicoplanin; Vancomycin | 2009 |
Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation.
Topics: Age Factors; Anti-Bacterial Agents; Blepharitis; Cephalosporins; Clarithromycin; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratoconjunctivitis; Meibomian Glands; Prevalence; Propionibacterium acnes; Sex Factors | 2012 |
Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Topics: Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Antimicrobial resistance in gram-positive bacteria.
Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecalis; Gastrointestinal Tract; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin Resistance | 2006 |
Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; Bronchitis, Chronic; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic | 2007 |
Efficacy and safety of cefepime: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic | 2007 |
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcal Skin Infections | 2007 |
New antimicrobial agents for the treatment of Gram-positive bacterial infections.
Topics: Acetamides; Anti-Infective Agents; Cephalosporins; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Virginiamycin | 2008 |
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
Topics: Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Drug Interactions; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Hospital-acquired infections: diseases with increasingly limited therapies.
Topics: Candidiasis; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
Topics: Administration, Oral; Aged; beta-Lactamases; Cefprozil; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant | 1993 |
[Cefotaxime (klaforan) in modern therapy of bacterial infections].
Topics: Anti-Bacterial Agents; Blood-Brain Barrier; Cefotaxime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1996 |
[The pathophysiology and treatment of severe intra-abdominal abscess].
Topics: Abdominal Abscess; Cefazolin; Cephalosporins; Enterococcus faecalis; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Intestines; Penicillins; Peritoneal Diseases; Piperacillin | 1996 |
Use of oral cephalosporins in infants and children.
Topics: Administration, Oral; Cephalosporins; Child; Child, Preschool; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Molecular Structure | 1997 |
[Contribution to the treatment of acute bovine mastitis with cefquinome].
Topics: Animals; Cattle; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mastitis, Bovine; Multicenter Studies as Topic | 1997 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
[Clinical implications of antibiotic resistance of enterococci].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Risk Factors | 1997 |
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Postoperative Complications; Teicoplanin | 1998 |
[Ceftibuten (Cedax)--a novel third generation oral cephalosporin in the treatment of bacterial infections].
Topics: Administration, Oral; Adult; Ceftibuten; Cephalosporins; Child, Preschool; Enterobacteriaceae Infections; Gram-Positive Bacterial Infections; Humans; Infant; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1998 |
Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections.
Topics: Abdomen; Appendicitis; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Pelvic Inflammatory Disease; Surgical Wound Infection | 1999 |
The final goal: penicillin-binding proteins and the target of cephalosporins.
Topics: Bacterial Proteins; Carrier Proteins; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hexosyltransferases; Humans; Kinetics; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Structure-Activity Relationship | 2000 |
Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Topics: Age Factors; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Economics, Pharmaceutical; Female Urogenital Diseases; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lyme Disease; Male Urogenital Diseases; Respiratory Tract Infections; Skin Diseases | 2001 |
[Risk factors and prevention of the acquisition and transmission of glycopeptide resistant enterococci].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Risk Factors; Vancomycin | 2001 |
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cross Infection; Drug Utilization; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Intestines; United States; Vancomycin Resistance | 2002 |
Which cephalosporin?
Topics: Bacterial Infections; Cefazolin; Cefoxitin; Cefuroxime; Cephalexin; Cephalosporins; Drug Costs; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans | 1992 |
[Enterococci: acquired antibiotic resistance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Urinary Tract Infections; Vancomycin | 1992 |
30 trial(s) available for cephalosporin c and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
A pharmacokinetic/pharmacodynamic analysis of ceftaroline prophylaxis in patients with external ventricular drains.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftaroline; Cephalosporins; Drainage; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neurosurgical Procedures; Prosthesis-Related Infections; Staphylococcus; Streptococcus pneumoniae | 2015 |
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2015 |
In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Cephalosporins; Drug Therapy, Combination; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2016 |
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Prophylactic cefdinir for pediatric cases of complicated urinary tract infection.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefdinir; Cephalosporins; Cohort Studies; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Secondary Prevention; Treatment Outcome; Urinary Tract Infections | 2011 |
Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Taiwan; Treatment Outcome; Urinary Tract Infections | 2002 |
Cefazolin dosing protocol for patients receiving long-term hemodialysis.
Topics: Aged; Cefazolin; Cephalosporins; Dose-Response Relationship, Drug; Female; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Humans; Male; Prospective Studies; Renal Dialysis | 2003 |
Coverage of enterococci in community acquired secondary peritonitis: results of a randomized trial.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Digestive System Surgical Procedures; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Peritonitis; Postoperative Complications; Prospective Studies; Reoperation; Sepsis; Surgical Wound Infection | 2000 |
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Topics: Aged; Ceftazidime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2008 |
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.
Topics: Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Single-dose ampicillin prophylaxis does not eradicate enterococcus from the lower genital tract.
Topics: Adult; Ampicillin; Cephalosporins; Cervix Uteri; Cesarean Section; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intraoperative Period; Postoperative Complications; Pregnancy; Premedication; Puerperal Infection; Vagina | 1993 |
Teicoplanin pharmacokinetics in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Microbial Sensitivity Tests; Monobactams; Teicoplanin | 1996 |
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.
Topics: Ceftazidime; Cephalosporins; Creatinine; Critical Illness; Cross-Over Studies; Female; Gram-Positive Bacterial Infections; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Serum Bactericidal Test | 1996 |
Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefoperazone; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; India; Injections, Intravenous; Male; Middle Aged; Treatment Outcome | 1995 |
Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia Study Group.
Topics: Adult; Cefpirome; Ceftazidime; Cephalosporins; Critical Care; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1998 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
Clinical studies of cefpirome in the treatment of urinary tract infections caused by Enterococcus faecalis.
Topics: Cefpirome; Cephalosporins; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Japan; Male; Microbial Sensitivity Tests; Treatment Outcome; Urinary Tract Infections | 1998 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin | 1998 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 1999 |
A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Postoperative Complications; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Vancomycin | 1999 |
Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefepime; Cephalosporins; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia | 1999 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefpirome; Cephalosporins; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 1999 |
[The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)].
Topics: Acute Disease; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Russia | 1999 |
[The role of cefepime, a 4th-generation cephalosporin, in treating patients with surgical sepsis].
Topics: Adolescent; Adult; Aged; Bacteremia; Cefepime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Middle Aged; Severity of Illness Index; Surgical Wound Infection; Systemic Inflammatory Response Syndrome | 1999 |
Association between cephalosporin therapy and subsequent nosocomial enterococcal colonization in surgical patients.
Topics: Adult; Antibiotic Prophylaxis; Cephalosporins; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors | 1999 |
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2000 |
Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cephalosporins; Double-Blind Method; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Thienamycins | 2000 |
Cefpirome versus ceftazidime in the treatment of urinary tract infections.
Topics: Cefpirome; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Urinary Tract Infections | 1992 |
113 other study(ies) available for cephalosporin c and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Predictors for vancomycin resistant
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Case-Control Studies; Cephalosporins; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Vascular Access Devices | 2019 |
In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2020 |
In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Haemophilus; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcus aureus; Taiwan | 2021 |
Evaluation of ultra-rapid susceptibility testing of ceftolozane-tazobactam by a flow cytometry assay directly from positive blood cultures.
Topics: Anti-Bacterial Agents; Blood Culture; Cephalosporins; Flow Cytometry; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Portugal; Spain; Tazobactam | 2020 |
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome | 2020 |
Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Cytarabine; Female; Gram-Positive Bacterial Infections; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Biofilms; Ceftaroline; Ceftriaxone; Cephalosporins; Cohort Studies; Drug Synergism; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2018 |
Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Klebsiella pneumoniae; Physicians; Pseudomonas aeruginosa; Republic of Korea; Specialization; Staphylococcus aureus | 2018 |
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States; Young Adult | 2019 |
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017).
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; United States | 2019 |
Prevalence and Predictors of Third-Generation Cephalosporin Resistance in the Empirical Treatment of Spontaneous Bacterial Peritonitis.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Cephalosporin Resistance; Cephalosporins; Databases, Factual; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minnesota; Peritonitis; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2019 |
Ceftobiprole for the treatment of infective endocarditis: A case series.
Topics: Adult; Aged; Aged, 80 and over; Cephalosporins; Daptomycin; Drug Therapy, Combination; Endocarditis; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 2020 |
Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Vancomycin | 2012 |
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Canada; Ceftaroline; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies | 2013 |
In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteroides fragilis; Ceftaroline; Cephalosporins; Coinfection; Drug Administration Schedule; Drug Combinations; Enterobacter cloacae; Escherichia coli; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome | 2013 |
Activity of ceftolozane-tazobactam against a broad spectrum of recent clinical anaerobic isolates.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides fragilis; Cephalosporins; Clostridium; Drug Combinations; Fusobacterium; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Prevotella; Propionibacterium; Tazobactam | 2014 |
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011).
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Epidemiological Monitoring; Global Health; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2014 |
Beta-lactamic resistance profiles in Porphyromonas, Prevotella, and Parvimonas species isolated from acute endodontic infections.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Dental Pulp Diseases; Gram-Positive Bacterial Infections; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Phenotype; Porphyromonas; Porphyromonas endodontalis; Porphyromonas gingivalis; Prevotella; Prevotella intermedia; Prevotella nigrescens | 2014 |
[Antimicrobial properties of ceftaroline fosamil].
Topics: Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2014 |
A new ASPECT for complicated urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability | 2015 |
Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections | 2015 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Antimicrobial-Resistant Fecal Bacteria from Ceftiofur-Treated and Nonantimicrobial-Treated Comingled Beef Cows at a Cow-Calf Operation.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Coinfection; Cross-Sectional Studies; Enterococcus; Escherichia coli; Escherichia coli Infections; Feces; Female; Gene Expression; Genes, Bacterial; Gram-Positive Bacterial Infections; Nebraska; Salmonella enterica; Salmonella Infections, Animal | 2016 |
Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
Topics: Ampicillin; Anti-Bacterial Agents; Biological Assay; Ceftaroline; Cephalosporins; Drug Combinations; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin Resistance | 2017 |
Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cephalosporins; Child; Child, Preschool; Cloxacillin; Drug Resistance, Bacterial; Female; Ghana; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Thienamycins | 2016 |
Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Ascites; Cephalosporins; Cohort Studies; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Korea; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
Presentation, treatment, and clinical course of otogenic lateral sinus thrombosis.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Cephalosporins; Cholesteatoma, Middle Ear; Chronic Disease; Combined Modality Therapy; Comorbidity; Disease Progression; Enterococcus; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Heparin; Hospitals, Teaching; Humans; Lateral Sinus Thrombosis; Magnetic Resonance Angiography; Male; Mastoid; Mastoiditis; Neurologic Examination; Otitis Media; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Retrospective Studies; Young Adult | 2009 |
Efficacy and safety of cefepime.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans | 2009 |
[Intravitreal injection of antibiotics in endophthalmitis].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Humans; Injections; Retinal Detachment; Vancomycin; Vitrectomy; Vitreous Body | 2008 |
[Pulmonary abscess due to Leuconostoc species in an immunocompetent patient].
Topics: Aged; Anti-Bacterial Agents; Bronchoscopy; Cephalosporins; Cryptogenic Organizing Pneumonia; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Leuconostoc; Lung Abscess; Male; Pulmonary Disease, Chronic Obstructive; Radiography | 2009 |
Designing a successful antimicrobial treatment against Devriesea agamarum infections in lizards.
Topics: Actinobacteria; Animals; Anti-Bacterial Agents; Cephalosporins; Dermatitis; Enrofloxacin; Fluoroquinolones; Gram-Positive Bacterial Infections; Lizards; Microbial Sensitivity Tests | 2009 |
Antimicrobial pressure and the emergence and spread of multiresistant enterococci.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Risk Factors; United States; Vancomycin Resistance | 2001 |
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporins; Colony Count, Microbial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests | 1981 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cephalosporins; Cetuximab; Ciprofloxacin; ErbB Receptors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Paronychia; Retrospective Studies; Skin | 2010 |
Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Risk Factors; Severity of Illness Index; Treatment Outcome | 2010 |
Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Female; Gentamicins; Gentian Violet; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Phenazines; Retrospective Studies; Treatment Outcome | 2010 |
Enterococcal peritonitis in children receiving chronic peritoneal dialysis.
Topics: Adolescent; Cephalosporins; Child; Child, Preschool; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infant; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Peritonitis; Prevalence; Registries; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucositis; Pharynx; Risk Factors; Transplantation, Homologous; Vancomycin; Young Adult | 2010 |
Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle East | 2011 |
Epidemiology of culture isolates from peritoneal dialysis peritonitis patients in southern India using an automated blood culture system to culture peritoneal dialysate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriological Techniques; Candida; Candidiasis; Cephalosporins; Child; Dialysis Solutions; Drug Resistance, Bacterial; Female; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; India; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Young Adult | 2011 |
In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
Topics: Anti-Bacterial Agents; Canada; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2011 |
Perioperative, postoperative, and prophylactic use of antibiotics in alloplastic total temporomandibular joint replacement surgery: a survey and preliminary guidelines.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacitracin; Biofilms; Cefazolin; Cephalosporins; Clindamycin; Device Removal; Disinfection; Gentamicins; Gram-Positive Bacterial Infections; Humans; Joint Prosthesis; Penicillins; Peptostreptococcus; Peroxides; Povidone-Iodine; Practice Guidelines as Topic; Practice Patterns, Dentists'; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temporomandibular Joint; Therapeutic Irrigation; Vancomycin | 2011 |
Rare case of large double perforated anterior mitral leaflet pseudoaneurysm in a patient with aortic valve endocarditis.
Topics: Aged; Aneurysm, False; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cefepime; Cephalosporins; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Endocarditis, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Tricuspid Valve Insufficiency; Vancomycin | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Reciprocal regulation of cephalosporin resistance in Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporin Resistance; Cephalosporins; Enterococcus faecalis; Gene Expression Regulation, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phosphorylation; Protein Phosphatase 2; Protein Serine-Threonine Kinases | 2011 |
First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Denmark; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Meropenem; Middle Aged; Mycoses; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thienamycins | 2012 |
Cefepime dosing in the morbidly obese patient population.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Surgical Wound Infection; Treatment Outcome | 2012 |
Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
Topics: Aged; Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Cephalosporins; Ciprofloxacin; Enterococcus; Female; Germany; Gram-Positive Bacterial Infections; Humans; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Male; Michigan; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Vancomycin Resistance | 2013 |
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Comorbidity; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Vancomycin; Vancomycin Resistance | 2012 |
[Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections].
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Digestive System Surgical Procedures; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Male; Middle Aged; Nitroimidazoles; Peritoneal Cavity; Ukraine | 2012 |
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Studies; Cephalosporins; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Metronidazole; Middle Aged; Risk Factors; Vancomycin; Vancomycin Resistance | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Disease Susceptibility; Female; Gallstones; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Penicillins; Treatment Outcome | 2003 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
Topics: Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli Infections; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Osteomyelitis; Staphylococcal Infections; Streptococcal Infections; United States | 2004 |
Cefdinir: an oral alternative to parenteral cephems.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 2005 |
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Treatment Outcome | 2005 |
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; North America | 2005 |
Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
Topics: Adult; Ascitic Fluid; Cephalosporins; DNA-Binding Proteins; Drug Therapy, Combination; Female; GATA3 Transcription Factor; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Interferon-gamma; Interleukin-12; Interleukin-18; Kidney Failure, Chronic; Leukocyte Count; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; RNA, Messenger; T-Box Domain Proteins; T-Lymphocyte Subsets; Teicoplanin; Th1 Cells; Th2 Cells; Trans-Activators; Transcription Factors; Treatment Outcome | 2005 |
Clinical outcomes of penicillin skin testing.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Penicillins; Practice Patterns, Physicians'; Retrospective Studies; Skin Tests; Vancomycin | 2005 |
Antimicrobial activity and spectrum of cefovecin, a new extended- spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; North America | 2006 |
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; North America; Sentinel Surveillance | 2007 |
Organisms causing spontaneous bacterial peritonitis in children with liver disease and ascites in Southern Iran.
Topics: Adolescent; Anti-Bacterial Agents; Ascites; Cephalosporins; Child; Child, Preschool; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Iran; Liver Diseases; Male; Peritonitis; Pneumococcal Infections; Streptococcus pneumoniae | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Synergism; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Streptomycin; Vancomycin Resistance | 2007 |
Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model.
Topics: Ampicillin Resistance; Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Dose-Response Relationship, Drug; Enterococcus faecalis; Gram-Positive Bacterial Infections; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Vancomycin Resistance | 2007 |
Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis in a neutropenic mouse thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Enterococcus faecalis; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Treatment Outcome | 2008 |
Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Culture Media; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rectum; Vancomycin Resistance | 2008 |
Endophthalmitis caused by Bacillus species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2008 |
New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Renal Dialysis; Thrombocytopenia; Vancomycin | 2008 |
In-vitro and in-vivo activity of DWC-751, a new cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1994 |
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
[Cephalosporins of the 4th generation. Further progress in antibacterial chemotherapy].
Topics: Bacterial Infections; Cefepime; Cefpirome; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1995 |
Problems with enterococci.
Topics: Cephalosporins; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1995 |
Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Mice; Time Factors | 1994 |
Bloodstream infections after interventional procedures in the biliary tract.
Topics: Bacteremia; Bile; Biliary Tract; Cephalosporins; Cholangiography; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Premedication; Radiology, Interventional; Risk Factors | 1994 |
Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Cephalosporins; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors | 1993 |
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis.
Topics: Amoxicillin; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Drug Synergism; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases | 1995 |
Antimicrobial susceptibilities of Lactococcus lactis and Lactococcus garvieae and a proposed method to discriminate between them.
Topics: Bacteriological Techniques; Cephalosporins; Cephalothin; Clindamycin; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Lactococcus; Lactococcus lactis; Microbial Sensitivity Tests; Penicillin Resistance; Species Specificity | 1996 |
Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol Resistance; Contact Lenses; Corneal Ulcer; Drug Resistance, Microbial; Equipment Contamination; Eye Diseases; Eye Injuries; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Keratitis; Male; Middle Aged; Occupational Diseases; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Singapore | 1995 |
In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
Topics: Animals; beta-Lactamases; Cephalosporins; Drug Stability; Enterobacteriaceae; Enzyme Induction; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1996 |
Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Mycobacterium tuberculosis; Pneumococcal Infections; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; Vancomycin | 1996 |
Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1996 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin | 1997 |
Reduced incidence of septic arthritis in children by Haemophilus influenzae type-b vaccination. Implications for treatment.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Child; Child, Preschool; Clindamycin; Cost Control; Diphtheria Toxoid; Finland; Gram-Positive Bacterial Infections; Haemophilus Infections; Haemophilus influenzae type b; Haemophilus Vaccines; Humans; Immunization; Incidence; Infant; Multicenter Studies as Topic; Prospective Studies; Safety; Staphylococcal Infections; Tetanus Toxoid; Vaccination; Vaccines, Conjugate | 1998 |
[Therapeutic effect of cefluprenam on polymicrobial urinary tract infection associated with Enterococcus faecalis, using the infectious urolithiasis model in rats].
Topics: Animals; Ceftazidime; Cephalosporins; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Urinary Calculi; Urinary Tract Infections | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Metabolic Clearance Rate; Methicillin Resistance; Microbial Sensitivity Tests; Renal Dialysis; Staphylococcus; Vancomycin; Wound Infection | 1998 |
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Multivariate Analysis; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin | 1998 |
Antibiotic prophylaxis.
Topics: Antibiotic Prophylaxis; Bile Duct Diseases; Catheterization, Central Venous; Cephalosporins; Enterococcus; Female Urogenital Diseases; Gram-Positive Bacterial Infections; Humans; Male Urogenital Diseases; Penicillins; Radiology, Interventional | 1999 |
AS-924, a novel bifunctional prodrug of ceftizoxime.
Topics: Animals; Bacteria; Ceftizoxime; Cephalosporins; Dogs; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Rabbits; Rats; Rats, Wistar | 1999 |
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Topics: Anti-Bacterial Agents; Carbapenems; Cefpirome; Cephalosporins; Chloramphenicol; Enterococcus faecalis; Enterococcus faecium; Europe; Fluoroquinolones; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
Late-developing infection in instrumented idiopathic scoliosis.
Topics: Adolescent; Cefazolin; Cephalosporins; Child; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Orthopedic Fixation Devices; Postoperative Complications; Prosthesis-Related Infections; Retrospective Studies; Scoliosis | 1999 |
Use of cefazolin for peritonitis treatment in peritoneal dialysis patients.
Topics: Cefazolin; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Retrospective Studies; Treatment Outcome | 1999 |
[The comparative activity of cefepime and other current antibiotics against microorganisms isolated from patients in pediatric intensive therapy units].
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units, Pediatric; Microbial Sensitivity Tests | 1999 |
An unusual case of pulmonary abscess.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Brain Abscess; Cefaclor; Cephalosporins; Diagnosis, Differential; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Metronidazole; Penicillins; Periodontal Abscess; Thoracic Vertebrae; Tomography, X-Ray Computed | 2000 |
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries | 2000 |
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance | 2000 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcaceae | 2001 |
[Prophylaxis with Tercef of infection-related complications following cesarean section].
Topics: Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Cesarean Section; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Pregnancy; Risk Factors; Time Factors | 2001 |
In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci.
Topics: Animals; Bacteria; Cephalosporins; Drug Resistance, Microbial; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Morpholines; Penicillin Resistance; Pneumococcal Infections; Pyridines; Time Factors | 2002 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-1992. A 55-year-old man with recurrent pericardial and pleural effusions after aortic-valve replacement.
Topics: Aortic Valve; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Pericarditis; Pleural Effusion; Postoperative Complications; Propionibacterium acnes; Suppuration; Vancomycin | 1992 |
Evaluation of the improvement of cephems on the prophylaxis of pelvic infection after radical hysterectomy.
Topics: Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Hysterectomy; Japan; Middle Aged; Pelvic Inflammatory Disease; Premedication; Retrospective Studies; Surgical Wound Infection | 1991 |